Introduction
Pseudoexfoliation (PEX) syndrome is an age-related microfibrillopathy disorder characterized by the deposition of grayish-white flaky exfoliative material in ocular and extraocular tissue [1 ]. It commonly affects patients over 50 years old (commonly in the late 60s and 70s) with prevalence ranging from 0.5 to more than 30% [2 ]. Although it occurs in virtually every area of the world, a considerable racial variation exists in its incidence. It is relatively rare among African-Americans and Eskimos. The prevalence is high in the Sami people who are indigenous of northern Europe [3 ]-[5 ]. There is also a high prevalence in Arabic populations. It is also well known that patients with PEX develop cataracts early in their lives [6 ]. Phacoemulsification is a preferred type of cataract surgery owing to fewer complications than other types [7 , 8 ]. However, it still has significant undesirable hazards such as posterior capsular rupture, vitreous loss, retinal detachment, cystoid macular edema, and posterior capsule opacification. Also, it can enhance loss of corneal endothelial cells , thickness, and density that may result in corneal decompensation and subsequent corneal transplantation [3 , 4 ]. In patients with PXF, small pupils and weak zonular support may enhance phacoemulsification complications [2 , 9 ]. Noncontact specular microscope is a noninvasive method for morphological analysis of corneal density of endothelial cells, ‘size change’ (polymegathism), and ‘hexagonal change’ (pleomorphism). Therefore, this technology plays an important role in preoperative evaluation, surgical design, and postoperative care [10 ].
The aim of the study was to compare the corneal endothelial cell changes after phacoemulsification in PXF patients relative to healthy adults using specular microscope.
Patients and methods
This prospective, nonrandomized comparative, interventional study was performed on 100 eyes of 100 patients who were divided equally into two groups (pseudoexfoliative and control). Patients who aged above 50 years and with nuclear cataract grades II, III, clear cornea, and endothelial cell density (ECD) more than 1000/mm2 were included in this study. Also, patients with normal anterior chamber depth, dilatable pupil, and with no active ocular disease or inflammation were included. Pseudoexfoliative patients who had glaucoma were excluded from the study.
The study is conducted in accordance with Helsinki standards as revised in 2013. All patients signed an informed written consent. Also, approval from the ethical committee of Faculty of Medicine Al-Azhar University Assiut was obtained before the study.
All patients were subjected to full medical history taking, general examination, and ophthalmic evaluation, including the best-corrected visual acuity using Landolt C chart. Intraocular pressure (IOP) (Goldman applanation tonometer) was also evaluated and measured at the same time of the day (from 10 am to 2 pm) to eliminate the effect of diurnal variation. Slit-lamp anterior-segment examination using slit lamp (LS3-450) besides fundus biomicroscopy to assess retina and optic disc by +90 D Volk noncontact lens was also conducted. Specular microscopy (NIDEK CEM 530, NIDEK Incorporation (eye & health care), California, USA) was done for all patients preoperatively, and data for central corneal ECD, hexagonal cells (HEX), and coefficient of variation (CV) were taken after exclusion of cases with abnormal specular parameters. Similar data were also assessed at 1 week, 1 month, and 6 months postoperatively.
All surgeries in the current study were done by the same technique (divide and conquer), same phaco machine, and single expert surgeon. Methyl cellulose was used as viscoelastic substance. Postoperative treatment was kept the same in all patients, including eye patch daily for 5 days, Moxifloxacin eye drops, Prednisolone 1% eye drops, and Tobramycin-dexamethasone eye ointment. On the first postoperative day, slit-lamp evaluation (to assess AC reaction and depth) and IOP was measured by Goldman applanation tonometer for early detection and management of early postoperative complications.
This study was carried out at a specialized eye center (modern eye center) in Assiut and took place between September 2019 and January 2021 after approval of its administration.
Statistical analysis
The mean and SD values were calculated for each group in each test. Data were explored for normality using Kolmogorov–Smirnov and Shapiro–Wilk tests and showed nonparametric (not normal) distribution.
Categorical variables were described by number and percent, where continuous variables were described by mean and SD. For parametric variables, independent samples and paired samples t test were used to compare between two groups in nonrelated and related samples, respectively. For nonparametric variables, Mann–Whitney and Wilcoxon t test were used to compare between two groups in nonrelated and related samples, respectively. The significance level was set at P value less than or equal to 0.05. Statistical analysis was performed with IBM SPSS Statistics, New York, USA version 26 for Windows.
Results
This was a prospective, nonrandomized, comparative, interventional study carried out on 100 patients divided into two groups. The mean age in group I (pseudoexfoliative group) was 55.52±2.94, while in group II (control group) was 55.12±2.96. In total, 26 (52%) patients of group I were males and 24 (48%) patients were females compared with 30 (60%) males and 20 (40%) females in group II. No significant difference was detected regarding age or sex between the two groups as shown in Table 1 .
Table 1: Demographic data of the studied groups
As regarding cataract grading in group I, 32% were soft, 24% were moderate, and 44% were hard, while in group II, 32% were soft, 40% were moderate, and 28% were hard without a significant difference between the two groups; P value of 0.151.
The preoperative evaluation of our patients revealed nonsignificant difference between the two groups regarding visual acuity and ECD (P =0.930, 0.356, respectively). However, the significant difference was detected in IOP of both groups (P =0.020) (Table 2 ).
Table 2: Preoperative data of the two studied groups
Regarding the postoperative evaluation of our groups, there were no significant differences between the two groups concerning ECD at 1 week, 1 month, and 6 months (P =0.223, 0.214, and 0.214, respectively) (Table 3 ). However, it is worth mentioning that in each group, there was a significant decline in endothelial cell count over the period of follow-up at 1 week, 1 month, and 6 months compared with the preoperative data as delineated in Table 4 . Moreover, the endothelial cell loss at each visit postoperatively was calculated in each group without a significant difference between the two groups at 1 week, 1 month, and 6 months (P =0.105, 0.087, and 0.082, respectively) (Table 5 ).
Table 3: Endothelial cell density in the studied groups.
Table 4: Multicomparison between all times calculated by paired samples t test
Table 5: Percent of endothelial cell loss 1 week, 1 month, and 6 months postoperatively
Similarly for cell-size changes postoperative, there was no significant difference between the two groups in the CV of cell size preoperatively and at 1 week, 1 month, and 6 months (P =0324,581 and 0.911, respectively) (Table 6 ). However, there was a statistically significant difference between the preoperative and postoperative CV in each group.
Table 6: Coefficient of variation in the studied groups
Also, for hexagonal corneal endothelial cells , no significant difference between the studied groups was detected either preoperative or during the follow-up period, including 1 week, 1 month, and 6 months (Table 7 ). When preoperative and postoperative data were compared in each group, there was a significant difference between preoperative hexagonality and the postoperative one in each group.
Table 7: Hexagonality in the studied groups
Discussion
This prospective case–control randomized study was carried out to compare the corneal endothelial cell changes after phacoemulsification in pseudoexfoliative patients relative to patients with cataract only. The above results showed that ECD significantly declined in both groups over the period of follow-up at 1 week, 1 month, and 6 months compared with the preoperative one. However, ECD and mean endothelial cell loss did not show a statistically significant difference between the PEX and the control group when compared at 1 week, 1 month, and 6 months postoperatively. Moreover, the mean endothelial cell loss at 1 week, 1 month, and 6 months was 10.63±0.88, 10.43±1.05, and 10.38±1.11 in the PEX group, and 10.1±2.14, 9.85±2.12, and 9.81±2.13 in the control group with no statistically significant difference between the two groups.
Similarly, in the prospective comparative study of Kristianslund et al. [11 ] that followed patients for two years after cataract surgery, the ECD was not found to be significantly different in PEX eyes compared with other eyes. Also, after 7 years of follow-up of cataract surgery in the study of Østern and Drolsum [12 ], they did not detect any significant difference in ECD in eyes with and without PEX. However, the study of Ekici et al. [13 ] showed that the mean ECD was significantly lower in PEX eyes than controls on the 7th and 30th days postoperatively. Also, Hayashi et al. [14 ] conducted a study on 36 patients with PEX matched to 36 non-PEX controls scheduled for phacoemulsification and delineated that endothelial cell loss was greater in eyes with PEX after surgery. Erdem et al. [15 ] reported that short-term endothelial cell loss was also higher in eyes with PEX than control. However, our study had the upper hand with a higher number of patients: 50 patients in both groups compared with the previous mentioned studies. Also, we had a longer follow-up period for 6 months postoperatively that gives a wider scope and a reliability and consistency to the results in both groups.
In addition to that, this study confirmed the current finding by the nonsignificant difference between the pseudoexfoliative group and the control group when comparing the mean endothelial cell loss at different times of follow-up. Similarly, Aygun et al. [16 ] found no differences between PEX patients and controls regarding endothelial cell loss. Also, the study of Østern and Drolsum [12 ] showed a nonsignificant difference in endothelial cell loss after cataract surgery between PEX and non-PEX eyes.
Regarding cell-size changes, the current study revealed that there was no statistically significant difference between the two studied groups preoperatively and postoperatively. This is in line with Ekici et al. [13 ], Erdem et al. [15 ], and Demircan et al. [17 ]. Also, we detected a statistically significant difference between the preoperative and postoperative CV in each group.
Concerning the percent of hexagonal endothelial cells, no statistically significant difference was found between the two studied groups either before or after surgery. However, there was a statistically significant difference between the preoperative and postoperative hexagonality in each group. In the study of Ekici et al. [13 ], there was also no significant difference regarding the HEX (pleomorphism) postoperatively between PEX and non-PEX eyes.
Thus, from the above-mentioned results, it is now obvious that changes in ECD, CV, and HEX could be detected in patients with and without PEX after cataract surgery without a significant difference between them. In the same point of view, Aygun et al. [16 ] proved that phacoemulsification may be conducted safely in eyes with PEX without a higher rate of complications. Also, Pardasani and Lohiya [18 ] reported a decrease in ECD and changes in CV and HEX after phacoemulsification surgery since endothelial cells cannot replicate to compensate cell loss.
In our study, we compared between many subgroups regarding the different follow-up evaluations between the pseudoexfoliative and control groups and within the same group. This variety of comparisons was scarcely addressed in previous research work. Therefore, and despite the fact that most of our findings are logical, easy to grasp, and consistent with previous work partly similar to ours, it is recommended to encourage more research work in the same area to confirm or deny the findings in our study.
The limitations of this study, short term of follow-up and low number of cases.
Conclusion
Specular microscopic changes of corneal endothelial cells after phacoemulsification are similar in patients with and without PEX. Thus, phacoemulsification may be performed in eyes with PEX without more susceptibility for complication.
Financial support and ponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi G.
Pseudoexfoliation syndrome and
pseudoexfoliation glaucoma: a review of the literature with updates on surgical management J Ophthalmol. 2015;2015:370371
2. Singh VM, Yerramneni R, Madia T, Prashanthi S, Vaddavalli PK, Reddy JC. Complications and visual outcomes of
cataract surgery in patients with
pseudoexfoliation Int Ophthalmol. 2021:1–12
3. Talebnejad MR, Azimi A, Khalili MR, Meshksar A. The role of trace elements in
pseudoexfoliation syndrome: a cross-sectional study J Ophthalmic Vis Res. 2021;16:165
4. Rao RQ, Arain TM, Ahad MA. The prevalence of
pseudoexfoliation syndrome in Pakistan. Hospital based study BMC Ophthalmol. 2006;6:1–5
5. Shazly TA, Farrag AN, Kamel A, Al-Hussaini AK. Prevalence of
pseudoexfoliation syndrome and
pseudoexfoliation glaucoma in Upper Egypt BMC Ophthalmol. 2011;11:1–6
6. Sangal N, Chen TC.
Cataract surgery in
pseudoexfoliation syndrome Seminars in ophthalmology. 2014;29 London [Black Square]: Taylor & Francis Group:403–408
7. Abd Elrasol AAA, Othman TEM, Abdalla AMEA, Gabr AF. Comparative study between corneal topographic changes following
phacoemulsification and small incision
cataract surgery Egypt J Hosp Med. 2021;84:1832–1838
8. Thanigasalam T, Reddy SC, Zaki RA. Factors associated with complications and postoperative visual outcomes of
cataract surgery; a study of 1,632 cases J Ophthalmic Vis Res. 2015;10:375
9. Hyams M, Mathalone N, Herskovitz M, Hod Y, Israeli D, Geyer O. Intraoperative complications of
phacoemulsification in eyes with and without
pseudoexfoliation Cataract Refract Surg. 2005;31:1002–1005
10. Palko JR, Qi O, Sheybani A. Corneal alterations associated with
pseudoexfoliation syndrome and glaucoma: a literature review J Ophthalmic Vis Res. 2017;12:312
11. Kristianslund O, Pathak M, Østern AE, Drolsum L. Corneal endothelial cell loss following
cataract surgery in patients with
pseudoexfoliation syndrome: a 2‐year prospective comparative study Acta Ophthalmol (Copenh). 2020;98:337–342
12. Østern AE, Drolsum L.
Corneal endothelial cells 6–7 years following
cataract surgery in patients with
pseudoexfoliation syndrome Acta Ophthalmol (Copenh). 2012;90:408–411
13. Ekici E, Keles A, Kahraman SK Early postoperative effects of uncomplicated
phacoemulsification surgery on
corneal endothelial cells and thickness in patients with
pseudoexfoliation syndrome. 2021
14. Hayashi K, Manabe SI, Yoshimura K, Kondo H. Corneal endothelial damage after
cataract surgery in eyes with
pseudoexfoliation syndrome J
Cataract Refract Surg. 2013;39:881–887
15. Erdem D, Elgin U, Sen E, Cankurtaran M. Short-term effects of
phacoemulsification surgery on corneal endothelium in
cataract cases with
pseudoexfoliation syndrome Glokom Katarakt. 2020;29:106–112
16. Aygun BT, Altan C, Kabakci AK. Comparison of
phacoemulsification parameters in eyes with and without exfoliation syndrome J Fran Ophtalmol. 2020;43:1031–1038
17. Demircan S, Atas M, Yurtsever Y. Effect of torsional mode
phacoemulsification on cornea in eyes with/without
pseudoexfoliation Int J Ophthalmol. 2015;8:281
18. Pardasani R, Lohiya S. Study of changes in corneal thickness and corneal endothelial cell density after
phacoemulsification cataract surgery J Evol Med Dent Sci. 2021;10:866–873